Roquefort Therapeutics (ROQ)

Sector:

Alternative Investment Instruments

 4.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 9.25
  • 52 Week Low: 4.00
  • Currency: UK Pounds
  • Shares Issued: 129.15m
  • Volume: 0
  • Market Cap: £5.75m

Regulatory News

Director/PDMR Shareholding 26-Jun-2023 10:00 RNS
RNA Medicine Shows In Vitro Anti-Cancer Efficacy 22-Jun-2023 07:00 RNS
Antibody Program Results & Orphan Drug Indication 19-Jun-2023 07:00 RNS
Anti-Cancer MDK mRNA - Positive in vitro Results 13-Jun-2023 07:00 RNS
Restoration of Trading 07-Jun-2023 10:11 RNS
Notice of Annual General Meeting 06-Jun-2023 07:00 RNS
Annual Report & Financial Statements - 31 Dec 2022 05-Jun-2023 07:00 RNS
Suspension of Trading Pending 2022 Annual Report 02-May-2023 07:56 RNS
Suspension - Roquefort Therapeutics plc 02-May-2023 07:30 RNS
Confirmation of No Exposure to Silicon Valley Bank 13-Mar-2023 07:30 RNS
Creation of New Novel Family of mRNA Therapeutics 08-Mar-2023 07:00 RNS
Formation of Scientific Advisory Board 06-Mar-2023 07:00 RNS
Randox Licence and Royalty Agreement 20-Feb-2023 07:00 RNS
MDK Oncology Antibodies Demonstrate In-Vivo Safety 24-Jan-2023 07:00 RNS
Holding(s) in Company 18-Jan-2023 08:36 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ROQ Market Data

Currency UK Pounds
Share Price 4.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 9.25
52 Week Low 4.00
Volume 0
Shares Issued 129.15m
Market Cap £5.75m

ROQ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.27% below the market average8.27% below the market average8.27% below the market average8.27% below the market average8.27% below the market average
42.37% above the sector average42.37% above the sector average42.37% above the sector average42.37% above the sector average42.37% above the sector average
Price Trend
71.74% below the market average71.74% below the market average71.74% below the market average71.74% below the market average71.74% below the market average
65.08% below the sector average65.08% below the sector average65.08% below the sector average65.08% below the sector average65.08% below the sector average
Income Not Available
Growth Not Available

ROQ Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page